Patients with bronchiectasis recovering from severe COVID-19 face higher risks of exacerbation and mortality compared to nonsevere cases. The study utilized data from Korea's National Health Insurance ...
Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results